Detection of gyrA Mutation Among Clinical Isolates of Campylobacter jejuni Isolated in Egypt by MAMA-PCR
Author(s) -
Mayar Maged Said,
Hanan El-Mohamady,
Fawkia M. El-Beih,
David Rockabrand,
Tharwat F. Ismail,
Marshall R. Monteville,
Salwa F. Ahmed,
John D. Klena,
Mohamed Salama
Publication year - 2010
Publication title -
the journal of infection in developing countries
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.322
H-Index - 49
eISSN - 2036-6590
pISSN - 1972-2680
DOI - 10.3855/jidc.963
Subject(s) - campylobacter jejuni , campylobacter , microbiology and biotechnology , ciprofloxacin , nalidixic acid , biology , campylobacter coli , dna gyrase , quinolone , antibiotics , gene , genetics , bacteria , escherichia coli
Campylobacter spp are the major cause of enteritis in humans and more than 90% of reported infections are caused by Campylobacter jejuni. Fluoroquinolones such as ciprofloxacin are the antibiotics of choice for treatment. An increase in the frequency of ciprofloxacin-resistant Campylobacter has been reported globally due to a single base mutation (C-257 to T) in codon 86 of the quinolone resistance determining region (QRDR) of the gyrA gene altering the amino acid sequence from threonine at position 86 to isoleucine (Thr-86 to Ile).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom